HOXA11 antisense lncRNA overexpression in ovarian cancer promoted cell proliferation, invasion, and migration by regulating the epithelial‐mesenchymal transition (EMT).5 Therefore, lncRNAs are expected to be new markers and targets for the diagnosis and treatment of malignant ovarian tumors. Here, HOXA11 is linked to ovarian carcinoma.